Improving Cell Quality & Enhancing Therapeutic Efficacy with CellPryme-M

Time: 3:30 pm
day: Day 1 – Track C – Afternoon


• Utilising the CellPryme-M technology to produce superior cells during the cell manufacturing process
• Producing cells that are less prone to exhaustion, enable longer duration of cancer killing activity, and are capable of improved tumour trafficking and penetrance compared to the current generation of CAR-T cells
• Enhancing performance in highly aggressive solid cancer models